MOG Protein 35-55, MOG Peptide Fragment human, >=98% (HPLC)

Amino Acid Sequence

Met-Glu-Val-Gly-Trp-Tyr-Arg-Pro-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys

Application

MOG Protein 35-55 is used as an antigen/immunogen to induce anti-MOG antibodies to induce experimental diseases such as experimental autoimmune encephalomyelitis (EAE) for study.

Biochem/physiol Actions

Myelin oligodendrocyte glycoprotein (MOG) is believed to function as an adhesion protein that support myelination of nerves. MOG is studied to understand the mechanisms of diseases such as adrenoleukodystrophy, vanishing white matter disease, multiple sclerosis (MS) and Rubella-induced mental retardation.

General description

Myelin oligodendrocyte glycoprotein (MOG) is widely expressed at the extracellular surface of myelin sheaths and oligodendrocytes in the central nervous system. The MOG gene is mapped to human chromosome 6p22.1.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Manufacturer Composition Storage Temp. Form Assay Price Quantity
3592473 MOG Protein 35-55, MOG Peptide Fragment human, >=98% (HPLC) SIGMA-ALDRICH Peptide Content, ≥75% −20°C lyophilized ≥95% (HPLC)
£391.25 (exc VAT) per 1MG
-
+
3592474 MOG Protein 35-55, MOG Peptide Fragment human, >=98% (HPLC) SIGMA-ALDRICH Peptide Content, ≥75% −20°C lyophilized ≥95% (HPLC)
£243.75 (exc VAT) per 500UG
-
+